Turklingua

Secure Turkish SAE Compliance for Global Clinical Data

Bridging the gap between global clinical trials and Turkish regulatory authorities with expert-led, high-precision pharmacovigilance translation services for your SUSAR and SAE documentation

TITCK Compliant NarrativesMedDRA & WHODrug Accuracy24/7 Urgent Safety Deadlines

Request an Urgent Safety Translation Quote

SUSAR / SAE Reports Turkish Translation

Are your SUSAR reports at risk of rejection by Turkish regulators due to inaccuracies?

Clinical safety data leaves no room for linguistic ambiguity when patient lives and regulatory standing are on the line

Regulatory Rejection

Improperly translated SAE narratives can trigger clinical trial suspensions and costly delays from TITCK

Medical Misinterpretation

Inaccurate MedDRA coding in Turkish leads to flawed signal detection and compromised patient safety profiles

Submission Delays

Missing the strict 7-day or 15-day reporting windows results in severe regulatory penalties globally

Critical Pharmacovigilance Documents We Translate

Comprehensive linguistic support for every stage of clinical safety reporting and adverse event tracking

SUSAR Initial Reports
SAE Follow-up Narratives
CIOMS I Forms
MedDRA Coding Summaries
Clinical Study Reports
Investigator Brochures
E2B R3 XML Data
PSUR Safety Updates
Benefit-Risk Evaluations
Informed Consent Forms
Patient Safety Narratives
DSUR Annual Reports
Ethics Committee Notifications
Clinical Trial Protocols
Pharmacovigilance Master Files
Regulatory Query Responses
Signal Detection Reports
Risk Management Plans
Adverse Event Tracking Logs
Medical Dictionary Mappings
SUSAR / SAE Reports Turkish Translation Expertise

Specialized Clinical Safety Translation Expertise

Where medical precision meets Turkish regulatory linguistic requirements

Handling SUSAR and SAE reports requires more than just language skills; it demands a deep clinical understanding of pharmacovigilance. Our team consists of subject-matter experts who specialize in translating complex adverse reaction narratives into Turkish while strictly adhering to the MedDRA and WHODrug terminologies required by local health authorities.

We recognize that time-critical reporting is the backbone of patient safety. Our internal protocols are designed to handle urgent 24-hour turnaround requests without sacrificing the linguistic integrity or medical accuracy of the data. Every report undergoes a rigorous validation process to ensure it is ready for immediate submission to the TITCK.

Our three decades of experience in the Turkish life sciences sector allow us to navigate the subtle nuances of regulatory phrasing. We ensure that every Serious Adverse Event is documented with the exact terminology needed to facilitate smooth communication between global sponsors and Turkish institutional review boards.

Why Turklingua Leads in Safety Reporting

The trusted linguistic partner for the world's preeminent pharmaceutical leaders

With over 30 years of experience, we have refined a specialized workflow specifically for pharmacovigilance and clinical safety, ensuring that every Turkish translation meets the highest standards of international medical compliance.

We utilize ISO-aligned quality assurance models that integrate SME-led reviews with advanced terminology management to guarantee consistency across thousands of pages of complex clinical documentation.

Our reputation as the Swiss Army Knife of Turkish language services is built on unrivaled precision and a deep commitment to protecting patient safety through clear and accurate communication.

Our Precision Safety Reporting Protocol

A streamlined six-step process designed for regulatory accuracy and rapid turnaround

01

Urgent Data Intake

We prioritize SAE/SUSAR files through a secure portal, immediately assessing the reporting timeline and clinical scope for Turkish translation

02

Medical SME Assignment

Your reports are assigned to MD-level linguists who possess specific expertise in pharmacovigilance and safety narrative construction

03

Precise Medical Translation

The content is translated using standardized MedDRA terminology, ensuring all adverse reactions are coded accurately for the Turkish market

04

Bilingual Quality Validation

A secondary subject-matter expert performs a cross-linguistic audit to verify the medical consistency of the safety data

05

Regulatory Alignment Check

We conduct a final review to ensure the Turkish narrative aligns perfectly with TITCK formatting and reporting requirements

06

Secure Rapid Delivery

The validated Turkish safety report is delivered ahead of the regulatory deadline via encrypted channels for immediate submission

Expert answers to your most critical pharmacovigilance translation questions

Strategic Safety Reporting Clarifications

How do you handle urgent 7-day SUSAR reporting deadlines?

We maintain an expedited workflow specifically for urgent safety data. By leveraging a dedicated team of medical SMEs, we can deliver high-quality Turkish translations within 24 to 48 hours, ensuring you never miss a critical TITCK submission window due to linguistic bottlenecks.

Do you use standardized MedDRA coding in your Turkish translations?

Yes, all our pharmacovigilance translations utilize the latest MedDRA version in Turkish. Our subject-matter experts are trained to map English medical terms to their exact Turkish regulatory equivalents, maintaining the coding integrity essential for global safety database synchronization.

Can you handle E2B R3 XML safety data files?

Our technical team is proficient in processing E2B (R3) XML structures. We can extract the narrative fields for Turkish translation and re-integrate them into the XML schema, ensuring the final file is technically compliant for electronic submission to Turkish health authorities.

How do you ensure the confidentiality of sensitive patient data?

We employ institutional-grade security measures, including end-to-end encryption and strict HIPAA-aligned data handling protocols. Our linguists operate under iron-clad NDAs, ensuring that all identifiable patient information in SAE reports remains completely confidential throughout the process.

Are your medical translators actually doctors or pharmacists?

Our clinical safety team consists of MDs, PharmDs, and medical researchers who have transitioned into professional linguistics. This ensures that the nuanced medical context of an adverse event is fully understood and accurately reflected in the Turkish narrative.

Do you provide certified translations for ethics committee submissions?

Absolutely. We provide certified and notarized translations that are recognized by Turkish Ethics Committees and the Ministry of Health. Our certifications serve as a guarantee of accuracy for all regulatory and legal purposes.

How do you manage terminology consistency across long-term trials?

We utilize advanced translation memory and client-specific glossaries. This ensures that a specific medical event or drug name is translated identically across all SUSARs, follow-up reports, and clinical study reports throughout the entire trial lifecycle.

Can you translate SAE narratives directly from handwritten investigator notes?

Yes, our experts are experienced in deciphering medical shorthand and handwritten clinical notes. We carefully transcribe and then translate these narratives into clear, professional Turkish, ensuring no critical safety observation is lost due to illegibility.

Validated Excellence in Clinical Safety

Trusted by global pharmaceutical leaders to secure their Turkish regulatory standing

Turklingua's ability to deliver accurate Turkish SUSARs under extreme deadlines is unmatched. Their medical SME linguists are truly impressive.

Director of Clinical Safety

Pharmaceuticals

San Francisco, CA, USA

We rely on Turklingua for all our SAE reporting in Turkey. Their MedDRA coding precision ensures our global data remains perfectly synchronized.

Head of Pharmacovigilance

Biotechnology

Basel, Switzerland

Navigating TITCK requirements was difficult until we found Turklingua. Their Turkish safety translations are consistently flawless and regulatory-ready.

Regulatory Affairs Manager

Clinical Research Organization

London, UK

Global Partners in Pharmacovigilance

Pfizer
Novartis
AstraZeneca
Roche
Sanofi
Takeda